Beyond the Breakthroughs: MIT Tech Review Preps Its List of 2025's 'Worst Technologies'
2025 saw major leaps in AI and biotech. But what about the failures? MIT Technology Review is set to reveal its annual list of the year's worst technologies, offering a critical look at what went wrong.
As 2025 draws to a close, it's clear the year was anything but quiet. Artificial intelligence became further embedded in our daily lives, weight-loss drugs expanded their reach, and the biotech world delivered some genuinely shocking developments in gene therapy, IVF, and neurotech.
According to its weekly biotech newsletter, 'The Checkup', the team at MIT Technology Review is already preparing its highly anticipated list of breakthrough technologies for 2026, slated for publication in the new year. But before they look forward, they're also looking back—with a critical eye.
Journalist Antonio Regalado is compiling his traditional, and arguably more provocative, list: the year's worst technologies. While the industry often celebrates its victories, this annual feature forces a necessary conversation about the missteps, the overhyped, and the ethically questionable innovations that marked the year. It serves as a crucial reality check on the true pace and direction of progress.
Authors
Related Articles
From hyper-personalized phishing to deepfake video calls, AI has turbocharged cybercrime. Meanwhile, hospitals adopt AI tools whose patient benefits remain unproven. What does this mean for trust?
Cohere and Aleph Alpha are merging to build a transatlantic AI challenger valued at $20 billion. Their pitch: sovereignty, not just performance. Can it work?
Google is committing up to $40 billion to Anthropic, a direct AI competitor. The deal reveals how the real AI arms race isn't about models — it's about who controls the infrastructure beneath them.
Amazon's fresh $5B investment in Anthropic brings its total to $13B. But the real story is a $100B AWS spending pledge and a bet on Amazon's own AI chips over Nvidia.
From hyper-personalized phishing to deepfake video calls, AI has turbocharged cybercrime. Meanwhile, hospitals adopt AI tools whose patient benefits remain unproven. What does this mean for trust?
Cohere and Aleph Alpha are merging to build a transatlantic AI challenger valued at $20 billion. Their pitch: sovereignty, not just performance. Can it work?
Google is committing up to $40 billion to Anthropic, a direct AI competitor. The deal reveals how the real AI arms race isn't about models — it's about who controls the infrastructure beneath them.
Amazon's fresh $5B investment in Anthropic brings its total to $13B. But the real story is a $100B AWS spending pledge and a bet on Amazon's own AI chips over Nvidia.
Thoughts
Share your thoughts on this article
Sign in to join the conversation